Gray Cameron 4
4 · Cue Biopharma, Inc. · Filed Jan 6, 2021
Insider Transaction Report
Form 4
Gray Cameron
Director
Transactions
- Award
Stock Option (right to buy)
2021-01-04+10,000→ 10,000 totalExercise: $12.36Exp: 2031-01-03→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy.
- [F2]This option was granted on January 4, 2021. The shares underlying the option are scheduled to vest in full on the anniversary of the grant date.